Nephrocare Health Services Ltd.
| Opening Date | Closing Date | Face Value | Issue Price | Lot Size | Listing At | Total Issue Size | Basis of Allotment | Initiation of Refunds | Credit of Shares to Demat | Listing Date |
|---|---|---|---|---|---|---|---|---|---|---|
| 10-12-2025 | 12-12-2025 | ₹2 per share | ₹438 to ₹460 per share | 32 Shares | BSE, NSE | 1,89,35,819 shares (aggregating up to ₹871.05 Cr) | 2025-12-15 00:00:00 | 2025-12-16 00:00:00 | 2025-12-16 00:00:00 | 17-12-2025 |
About The Company
Nephrocare Health IPO is a book build issue of ₹871.05 crores. The issue is a combination of fresh issue of 0.77 crore shares aggregating to ₹353.40 crores and offer for sale of 1.13 crore shares aggregating to ₹517.64 crores.
Nephrocare Health IPO opens for subscription on Dec 10, 2025 and closes on Dec 12, 2025. The allotment for the Nephrocare Health IPO is expected to be finalized on Dec 15, 2025. Nephrocare Health IPO will list on BSE, NSE with a tentative listing date fixed as Dec 17, 2025.
Nephrocare Health IPO price band is set at ₹438.00 to ₹460.00 per share . The lot size for an application is 32. The minimum amount of investment required by an retail is ₹14,720 (32 shares) (based on upper price). The lot size investment for sNII is 14 lots (448 shares), amounting to ₹2,06,080, and for bNII, it is 68 lots (2,176 shares), amounting to ₹10,00,960.
Financials
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrow |
|---|---|---|---|---|---|---|
| 31-03-2023 | 666 | 443 | -12 | 384.73 | 383.5 | 196.21 |
| 31-03-2024 | 0 | 0 | ||||
| 01-01-1970 | 0 | 0 | ||||
| 01-01-1970 | 0 | 0 |
IPO Subscription Status
| Category | Subscription Times |
|---|---|
| Anchor Investors | 1 |
| QIB (Ex Anchor) | 26.82 |
| Non-Institutional Buyers | 24.77 |
| Retail Investors | 2.36 |
| Employees | 2.81 |
| Total | 14.08 |
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 32 | 14720 |
| Retail (Max) | 13 | 416 | 191360 |
| S-HNI (Min) | 14 | 448 | 206080 |
| S-HNI (Max) | 67 | 2144 | 986240 |
| B-HNI (Min) | 68 | 2176 | 1000960 |
IPO Listing Details
| Listing Date | 17-12-2025 |
| BSE Script Code | |
| NSE Symbol | |
| ISIN | |
| Final Issue Price | 460 |
Promoter holdings
Vikram Vuppala, Bessemer Venture Partners Trust, Edoras Investment Holdings Pte. Ltd., Healthcare Parent Limited, Investcorp Private Equity Fund II and Investcorp Growth Opportunity Fund
Contact Information of the Company
Nephrocare Health Services Ltd.
5 th Floor, D Block, iLabs Centre,
Plot 18, Software Units Layout,
Survey No. 64, Madhapur, Shaikpet,
Hyderabad, Telangana, 500081
Phone: +91 40 4240 8039
Email: cs@nephroplus.com
Website: http://www.nephroplus.com/
IPO Registrar
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: nephrocare.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
IPO Lead Manager
ICICI Securities Ltd. Ambit Pvt. Ltd. IIFL Capital Services Ltd. Nomura Financial Advisory & Securities (India) Pvt. Ltd.